Status:
WITHDRAWN
Image Fusion and Calcification Raising in Trans Aortic Valve Implantation
Lead Sponsor:
Nantes University Hospital
Conditions:
Symptomatic Aortic Stenosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aortic stenosis is one of the most common cardiology diseases. Trans aortic valve implantation (TAVI) has been developed since 2002, first to treat rejected patients from conventional surgery, then to...
Detailed Description
Aortic stenosis is one of the most common cardiology diseases. If untreated, symptomatic aortic stenosis rapidly leads to death. Most of the time, this disease affects old fragile people for whom conv...
Eligibility Criteria
Inclusion
- All patients admitted in Nantes CHU for trans fermoral aortic valve replacement with SAPIEN 3® device
- Patient who accepted to participate to the study
Exclusion
- Impossible written consent
- Judiciary protected people
- Minor
- Women of childbearing age without contraception
Key Trial Info
Start Date :
September 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03247465
Start Date
September 13 2017
End Date
September 13 2017
Last Update
September 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093